Home › Funds › Two Sigma Investments › SABS
Two Sigma Investments position in SABS
SAB BIOTHERAPEUTICS INC · Health Care
Latest position (Q2 2026)214.63K sh
Reported value held$837.07K
Portfolio Weight0.00%
First reportedQ2 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2023 | 25.09K | $20.83K | New |
| Q1 2026 | 181.19K | $693.94K | New |
| Q2 2026 | 214.63K | $837.07K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SABS
- Balyasny Asset Management 3.76M sh · $14.67M · Q2 2026
- BlackRock Inc 3.07M sh · $11.96M · Q2 2026
- Millennium Management 2.75M sh · $10.72M · Q2 2026
- Vanguard Group 1.85M sh · $6.91M · Q4 2025
- Geode Capital Management 1.28M sh · $4.98M · Q2 2026
- UBS Group AG 365.88K sh · $1.43M · Q2 2026
- Northern Trust Corp 362.49K sh · $1.41M · Q2 2026
- Goldman Sachs Group 191.31K sh · $746.09K · Q2 2026
- Citadel Advisors 143.80K sh · $560.81K · Q2 2026
- BNY Mellon 107.85K sh · $420.60K · Q2 2026
- Charles Schwab Investment Management 105.68K sh · $412.16K · Q2 2026